Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Psychemedics (PMD) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 124,160
  • Shares Outstanding, K 5,460
  • Annual Sales, $ 26,980 K
  • Annual Income, $ 1,510 K
  • 36-Month Beta 0.87
  • Price/Sales 4.60
  • Price/Book 8.93

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.25 +2.20%
on 11/10/16
26.00 -12.54%
on 11/18/16
+0.46 (+2.06%)
since 11/04/16
3-Month
18.06 +25.91%
on 10/26/16
26.00 -12.54%
on 11/18/16
+2.65 (+13.19%)
since 09/02/16
52-Week
7.76 +193.04%
on 01/20/16
26.00 -12.54%
on 11/18/16
+11.64 (+104.86%)
since 12/04/15

Most Recent Stories

More News
Psychemedics Shares Up 57.6% Since SmarTrend's Buy Recommendation (PMD)

SmarTrend identified an Uptrend for Psychemedics (NASDAQ:PMD) on July 8th, 2016 at $14.46. In approximately 4 months, Psychemedics has returned 57.61% as of today's recent price of $22.79.

Psychemedics Up 62.4% Since SmarTrend Uptrend Call (PMD)

SmarTrend identified an Uptrend for Psychemedics (NASDAQ:PMD) on July 8th, 2016 at $14.46. In approximately 4 months, Psychemedics has returned 62.38% as of today's recent price of $23.48.

Psychemedics Corporation Announces Record Revenues and Earnings

Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September 30, 2016. The Company also announced a quarterly dividend of $0.15 per share payable...

Psychemedics Shares Up 31.4% Since SmarTrend's Buy Recommendation (PMD)

SmarTrend identified an Uptrend for Psychemedics (NASDAQ:PMD) on July 8th, 2016 at $14.46. In approximately 4 months, Psychemedics has returned 31.40% as of today's recent price of $19.00.

35.6% Return Seen to Date on SmarTrend Psychemedics Call (PMD)

SmarTrend identified an Uptrend for Psychemedics (NASDAQ:PMD) on July 8th, 2016 at $14.46. In approximately 3 months, Psychemedics has returned 35.62% as of today's recent price of $19.61.

Uptrend Call Working As Psychemedics Stock Rises 37.6% (PMD)

SmarTrend identified an Uptrend for Psychemedics (NASDAQ:PMD) on July 8th, 2016 at $14.46. In approximately 3 months, Psychemedics has returned 37.55% as of today's recent price of $19.89.

Shares of PMD Up 39.0% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Psychemedics (NASDAQ:PMD) on July 8th, 2016 at $14.46. In approximately 3 months, Psychemedics has returned 39.00% as of today's recent price of $20.10.

39.3% Return Seen to Date on SmarTrend Psychemedics Call (PMD)

SmarTrend identified an Uptrend for Psychemedics (NASDAQ:PMD) on July 8th, 2016 at $14.46. In approximately 3 months, Psychemedics has returned 39.35% as of today's recent price of $20.15.

Uptrend Call Working As Psychemedics Stock Rises 37.9% (PMD)

SmarTrend identified an Uptrend for Psychemedics (NASDAQ:PMD) on July 8th, 2016 at $14.46. In approximately 2 months, Psychemedics has returned 37.90% as of today's recent price of $19.94.

Psychemedics Corporation Earns Prestigious Recognition for Superior Customer Service

Psychemedics Corporation (NASDAQ: PMD), the world's leading and largest hair analysis drug testing company, announced that it has been certified as a Center of Excellence by BenchmarkPortal. The Center...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.

See More

Support & Resistance

2nd Resistance Point 23.23
1st Resistance Point 22.99
Last Price 22.74
1st Support Level 22.57
2nd Support Level 22.39

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.